Francisco Partners has completed an investment in Therapeutic Research Center, a provider of drug therapy recommendations, continuing education, training, and data to the healthcare community.
“We see a growing need for reliable information for healthcare professionals as advances in technology and a growing patient population combine to make the practice of medicine increasingly complex,” said Chris Adams, a principal with Francisco Partners. “Therapeutic Research Center is one of the most trusted platforms in healthcare, and we look forward to supporting the company in its continued growth.”
Therapeutic Research Center is a research, analytic, and information services organization that provides evidence-based drug therapy recommendations for physicians, pharmacists, pharmacy technicians, and other healthcare professionals. The company also provides information on natural medicines to institutions and individual consumers. Therapeutic Research Center’s information products include Pharmacist’s Letter, Prescriber’s Letter, Pharmacy Technician’s Letter, Natural Medicines Comprehensive Database, Ident-A-Drug Reference, and a variety of continuing education and training courses. The company also operates Pharmacy Technicians University, an online education platform focused on the training and certification of pharmacy technicians. The company was founded in 1985 and is based in Stockton, CA (www.therapeuticresearch.com).
“We founded Therapeutic Research Center with the mission of providing healthcare professionals with high-quality, unbiased information and recommendations that improve patient care and patient outcomes,” said Jeff Jellin, founder and editor-in-chief of Therapeutic Research Center. “Francisco Partners’ deep technology expertise will help us incorporate new technology and tools to better inform and educate healthcare professionals and help achieve our core mission.”
Francisco Partners pursues investments in technology companies with transaction values ranging from $50 million to $2 billion. Transaction structures include buyouts, divisional divestitures, recapitalizations, restructurings and growth equity financings. Francisco Partners is headquartered in San Francisco, CA (www.franciscopartners.com).
Shearman & Sterling acted as legal advisor to Francisco Partners. Berkery, Noyes & Co. served as the financial advisor to Therapeutic Research Center, and Choate Hall and Stewart provided legal counsel to the company.
